Aldesleukin Recruiting Phase 2 Trials for Glioblastomas / Gastrointestinal/Genitourinary Cancer / Breast Cancer / Lung Cancer Non-Small Cell Cancer (NSCLC) / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04102436Non-Viral TCR Gene Therapy
NCT03412877Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in People With Metastatic Cancer